Clinical Trial Update: A Research Study on Etavopivat in Participants With and Without Liver Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating etavopivat in participants with and without liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Etavopivat (Etavopivat)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Liver Diseases | Phase 1 | Status: COMPLETED